State Street’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
|
|||||
|
2025
Q2 | $10.6M | Sell |
|
|||||
|
2025
Q1 | $9.45M | Sell |
|
|||||
|
2024
Q4 | $6.91M | Sell |
|
|||||
|
2024
Q3 | $21.1M | Buy |
|
|||||
|
2024
Q2 | $26.9M | Sell |
|
|||||
|
2024
Q1 | $84.2M | Buy |
|
|||||
|
2023
Q4 | $84.9M | Sell |
|
|||||
|
2023
Q3 | $90.1M | Buy |
|
|||||
|
2023
Q2 | $108M | Sell |
|
|||||
|
2023
Q1 | $115M | Buy |
|
|||||
|
2022
Q4 | $104M | Sell |
|
|||||
|
2022
Q3 | $116M | Buy |
|
|||||
|
2022
Q2 | $94.8M | Buy |
|
|||||
|
2022
Q1 | $93.8M | Buy |
|
|||||
|
2021
Q4 | $92.2M | Buy |
|
|||||
|
2021
Q3 | $87.6M | Buy |
|
|||||
|
2021
Q2 | $75.9M | Buy |
|
|||||
|
2021
Q1 | $94.1M | Sell |
|
|||||
|
2020
Q4 | $133M | Buy |
|
|||||
|
2020
Q3 | $91M | Sell |
|
|||||
|
2020
Q2 | $88M | Buy |
|
|||||
|
2020
Q1 | $48.4M | Buy |
|
|||||
|
2019
Q4 | $120M | Buy |
|
|||||
|
2019
Q3 | $146M | Buy |
|
|||||
|
2019
Q2 | $175M | Sell |
|
|||||
|
2019
Q1 | $166M | Sell |
|
|||||
|
2018
Q4 | $102M | Buy |
|
|||||
|
2018
Q3 | $142M | Buy |
|
|||||
|
2018
Q2 | $156M | Sell |
|
|||||
|
2018
Q1 | $199M | Buy |
|
|||||
|
2017
Q4 | $185M | Sell |
|
|||||
|
2017
Q3 | $77.4M | Buy |
|
|||||
|
2017
Q2 | $96.6M | Buy |
|
|||||
|
2017
Q1 | $80M | Sell |
|
|||||
|
2016
Q4 | $59.1M | Sell |
|
|||||
|
2016
Q3 | $53.9M | Buy |
|
|||||
|
2016
Q2 | $28M | Buy |
|
|||||
|
2016
Q1 | $23.2M | Buy |
|
|||||
|
2015
Q4 | $31M | Sell |
|
|||||
|
2015
Q3 | $26.4M | Buy |
|
|||||
|
2015
Q2 | $35.2M | Buy |
|
|||||
|
2015
Q1 | $3.76M | Buy |
|
|||||
|
2014
Q4 | $2.67M | Buy |
|
|||||
|
2014
Q3 | $1.51M | Buy |
|